A British man suffering from a fatal brain tumor has recovered after taking part in a clinical trial.
- A British man enrolled in a clinical trial after being diagnosed with glioblastoma, the most common brain cancer in adults.
- During the study, the patient received immunotherapy treatment before undergoing surgery, then chemotherapy and radiotherapy.
- After the trial, the deadly brain tumor disappeared. The doctors in charge of this case hailed an unprecedented recovery.
In 2022, Ben Trotman, a 41-year-old Briton, learned that he had glioblastoma, the most common brain cancer in adults. When the diagnosis was announced, doctors told him that he only had nine months left to live. The patient therefore enrolled in a global clinical trial of treatment for this brain tumor.
Brain cancer: an “unprecedented” cure
Since the early 2000s, treatment for glioblastoma has been based on surgery aimed at removing as much of the tumor as possible. Patients then undergo chemotherapy as well as radiotherapy. Unfortunately, the condition generally recurs and leads to the death of patients.
As part of the new study, Ben Trotman initially received immunotherapy treatment, before benefiting from the usual care. THE patient experienced intense headaches after administration of the immunotherapy drug, which is not yet available. According to doctors, this sign was positive because it showed that his immune system had “wake up” and attacked the tumor.
Brain cancer: new treatments soon available?
To everyone’s surprise, the deadly brain tumor disappeared after the start of therapy, according to information relayed by the Daily mail. At present, the patient leads a normal life. Doctors handling Ben Trotman’s case said his remarkable recovery was “unpublished” and welcomed a cure “unprecedented”.
Dr. Paul Mulholland, head of the trial and a brain cancer specialist at University College Hospital in London, said the results are so promising that new treatments could soon emerge. “I believe we have the tools to cure the disease. We need to intervene early to give patients the best chance of long-term survival. This is important not only for brain cancer patients, but also for all other cancers with poor survival, such as pancreatic cancer”he concluded.
Check out our digital video work,
only an account creation is required to access it.
